Market News
Stay updated with the latest market trends, earnings, and economic indicators.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Watch: Alka Yagnik's Wheelchair Video After Padma Bhushan Honour Raises Health Concerns; Singer Responds
Alka Yagnik was honoured with India's third-highest civilian award, the Padma Bhushan, by President Droupadi Murmu.
Citizens reiterates NRC Health stock rating on growth outlook By Investing.com - Investing.com India
Citizens reiterates NRC Health stock rating on growth outlook By Investing.comInvesting.com India
Volumes jump at Global Health Ltd counter
Global Health Ltd saw volume of 10.02 lakh shares by 10:46 IST on BSE, a 60.42 fold spurt over two-week average daily volume of 16586 shares
Deep Health AI reduces stake in Exxaro Tiles to 5.98% - scanx.trade
Deep Health AI reduces stake in Exxaro Tiles to 5.98%scanx.trade
Citizens reiterates agilon health stock rating ahead of forum By Investing.com - Investing.com India
Citizens reiterates agilon health stock rating ahead of forum By Investing.comInvesting.com India
Biocon's Malaysian partner Duopharma Biotech secures insulin tenders worth over MYR 225 million
Biocon said that its long-standing partner Duopharma Biotech has secured multiple insulin contracts from the Ministry of Health (MoH), Malaysia, valued at over MYR 225 million this year.
Biocon secures multiple insulin contracts from Ministry of Health, Malaysia
Biocon announced that its long-standing partner, Duopharma Biotech Berhad (Duopharma Biotech) via its wholly-owned subsidiary Duopharma (M) Sendirian Berhad, has secured multiple insulin contracts from the Ministry of Health (MoH), Malaysia, valued at over MYR 225 million this year.
Shilpa Biologicals commissions Antibody-Drug Conjugate (ADC) GMP manufacturing facility
Shilpa Biologicals, a material subsidiary of Shilpa Medicare, announced the commissioning of a state-of-the-art Antibody-Drug Conjugate (ADC) GMP manufacturing facility, purpose-built and designed to meet global regulatory approval standards including US FDA, EMA, and other major health authority requirements. The facility is fully operational, with GMP qualification protocols now actively underway, placing Shilpa on a clear path to commercial readiness.
True Health Medical Share Price Today | HK: 2697 - Investing.com India
True Health Medical Share Price Today | HK: 2697Investing.com India
Sri Lanka Bans Junk Food In Schools To Combat Rising Child Health Issues
Schools are forbidden from serving food that has high amounts of sugar, salt, and fat.
Mamaearth Enters 'Beauty-From-Within' Segment As Parent Honasa Acquires 58% In Nutraceuticals Firm
The company will enter the category by establishing a dedicated subsidiary, Honasa Health Pvt.